Houston voices

University of Houston: How to navigate 'altmetrics' in your innovative research project

There are a few things to remember about altmetrics when tapping into non-traditional methods of metrics reporting. Graphic byMiguel Tovar/University of Houston

Alternative metrics, or “altmetrics,” refers to the use of non-traditional methods for judging a researcher’s reach and impact.

Being published in a peer-reviewed journal is surely a great feat. It’s the typical way professors get their research out there. But the tools established to measure this output might end up giving the skewed impression about an author’s impact in spheres both academic and social.

Traditional metrics

Web of Science and Scopus are the main platforms that researchers rely on for collecting article citations. Web of Science’s indexing goes back to 1900, and Scopus boasts the largest database abstract and citations. The caveat with these repositories is that each resource only gives you a rating based on the range and breadth of journals it indexes. Different journals are recorded in different tools, so you may not be getting a comprehensive metric from either.

Let’s talk about h index

The h index is probably never going away, although it is always being improved upon.

An h index is a complex equation that tells the story of how often a researcher is cited. For instance, if a scholar published six papers, and all six papers were each cited by at least six other authors, they would have an h index of 6.

This equation doesn’t work out too well for an academic who, say, had one paper that was continuously cited – they would still have an h index of 1. Brené Brown, Ph.D., even with her veritable empire of vulnerability and shame related self-help has h index of 7 according to Semantic Scholar.

On to altmetrics

When a psychology professor goes on a morning show to discuss self-esteem of young Black women, for instance, she is not helping her h index. Her societal impact is huge, however.

“When I use altmetrics to deliver a professor his or her impact report, I seek out nontraditional sources like social media. For instance, I check how many shares, comments or likes they received for their research. Or maybe their work was reported in the news,” said Andrea Malone, Research Visibility and Impact Coordinator at the University of Houston Libraries.

Altmetrics aim to answer the question of how academia accounts for the numerous other ways scholarly work impacts our society. What about performances done in the humanities, exhibitions, gallery shows or novels published by creative writers?

Alternative metrics are especially important for research done in the humanities and arts but can offer social science and hard science practitioners a better sense of their scope as well. With the constant connections we foster in our lives, the bubble of social media and such, there is a niche for everyone.

The equalizer

For some, Twitter or Facebook is where they like to publish or advertise their data or results.

“When altmetrics are employed, the general public finds out about research, and is able to comment, share and like. They can talk about it on Twitter. The impact of the work is outside of academia,” said Malone. She even checks a database to see if any of the professor’s works have been included in syllabi around the country.

Academia.edu is another social network offering a platform for publishing and searching scholarly content. It has a fee for premium access, whereas Google Scholar is free. Its profile numbers are usually high because it can pick up any public data – even a slide of a PowerPoint.

The Big Idea

At the University of Houston, altmetrics are categorized thusly: articles, books and book chapters, data, posters, slides and videos. While one would think there’s no downside to recording all of the many places academic work ends up, there are a few things to remember about altmetrics:

  1. They lack a standard definition. But this is being worked on currently by the NISO Alternative Assessment Metrics Initiative.
  2. Altmetrics data are not normalized. Tell a story with your metrics, but don’t compare between two unlike sources. Youtube and Twitter will deliver different insights about your research, but they can’t be compared as though they measure the same exact thing.
  3. They are time-dependent. Don’t be discouraged if an older paper doesn’t have much to show as far as altmetrics. The newer the research, the more likely it will have a social media footprint, for example.
  4. They have known tracking issues. Altmetrics work best with items that have a Digital Object Identifier (DOI).

So have an untraditional go of it and enlist help from a librarian or researcher to determine where your research is making the biggest societal impact.

------

This article originally appeared on the University of Houston's The Big Idea. Sarah Hill, the author of this piece, is the communications manager for the UH Division of Research.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News